We reveal that curcumin enhances the anti-tumor effects of gefitinib in various resistant NSCLC cancer cell lines by modulating the EGFR protein kinase activity which leads to reduce the cancer cells growth ability and promotes cell apoptosis in vitro. Here, EGFR is linked to neoplasm.